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Abstract
The intercostobrachial nerve (ICBN), which usually originates from the lateral cutaneous
branch of the second intercostal nerve, innervates areas of the axilla, lateral chest, and medial
arm. It is at risk for injury during operative procedures that are often used in the management
of breast cancer and such injury has been associated with postoperative sensory loss and
neuropathic pain, decreasing the quality of life.
PubMed, Excerpta Medica Database (EMBASE), ScienceDirect, Google Scholar, China National
Knowledge Infrastructure (CNKI), Scientific Electronic Library Online (SciELO), Biosciences
Information Service (BIOSIS), and Web of Science were searched comprehensively. Data
concerning the prevalence, branching, origin and communications of the ICBN were extracted
and pooled into a meta-analysis.
A total of 16 studies (1,567 axillas) reported data indicating that the ICBN was present in 98.4%
of person. It most often (90.6%) originated from fibers at the T2 spinal level and commonly
coursed in two branching patterns: as a single trunk in 47.0% of cases and as a bifurcating
pattern in 42.2%. In the latter cases, the bifurcation was usually unequal (63.4%). Additionally,
the ICBN presented with anastomosing communication to the brachial plexus in 41.3% of
cases.
The ICBN is a prevalent and variable structure at significant risk for injury during operative
procedures of the axilla. In view of the postoperative pain and paresthesia experienced by
patients following injury, surgeons need to exercise caution and aim to preserve the ICBN when
possible. Ultimately, careful dissection and knowledge of ICBN anatomy could allow
postoperative complications to be reduced and patient's quality of life increased.
Categories: Oncology, General Surgery, Pain Management
Keywords: axillary dissection, breast cancer, intercostobrachial nerve, mastectomy, neuropathy,
oncological surgery
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Introduction And Background
The intercostobrachial nerve (ICBN) is a nerve classically originating from the lateral cutaneous
branch of the second intercostal nerve [1]. The ICBN functions to innervate portions of the
axilla, tail of the breast, lateral chest wall and medial side of the arm [2-3]. The ICBN, in its
historically portrayed course, exits the second intercostal space and traverses the axilla to
terminally branch in the region of the medial arm [1]. The proximity and course of the ICBN in
relation to the axilla poses a danger of iatrogenic injury resulting from common procedures
such as axillary lymph node dissection (ALND), sentinel lymph node biopsy (SLNB) and
mastectomy [2,4].
Breast cancer is the most common malignancy in women worldwide, affecting nearly one in
eight in both the United States and Europe [1, 5-6]. Procedures such as ALND, SLNB, and/or
mastectomy are utilized in a significant portion of breast cancer cases for purposes ranging
from diagnosis, staging, to resection [1, 7-8]. The ICBN is the most commonly injured nerve
during mastectomy and is believed to be implicated in both persistent pain after breast cancer
treatment (PPBCT) and permanent loss of sensory function in the region supplied [1-2,9].
It has been estimated that between 10-60% of breast cancer survivors who have undergone
operative procedures, experience PPBCT, and it is believed that this predominantly neuropathic
pain contributes significantly to a reduced quality of life following breast cancer treatment [1,
9-10]. Aside from dysesthesia, paresthesia of the ICBN, sensory distribution is also very
common [11]. It has been shown that preservation of the ICBN provides for a clear reduction in
post-procedural paresthesia and improves the quality of life [1, 11]. Surgeons should exercise
precision during dissections of the axillary region as early branching and anastomosing fibers
between the ICBN and brachial plexus can easily be overlooked [1, 12-13].
ICBN anatomy has been studied in detail in the past two decades, yet on a very limited scale.
The ICBN’s structure is highly variable in nature with numerous origins, branching patterns and
communicating branches [1, 4-13-17]. Determining the true prevalence and nature of the
variant patterns of ICBN branching and origin will serve surgeons to better preserve these
neural structures. A surgeon’s knowledge of these structures is vital to their safeguarding
during operative breast cancer management. The clinical importance of the ICBN necessitates
further investigations in the future, because despite the development of detailed anatomical
investigations that are becoming more widespread, the ICBN remains an overlooked structure.
The aim of this study was to utilize all available data to date to provide a comprehensive
evidence-based appraisal of the prevalence and varying patterns of ICBN origin and branching.
It is our intention, that this information be utilized to help decrease the morbidity and risk of
postoperative complications of breast cancer treatment.
Review
Methods
Search Strategy
Identification of articles for inclusion in the meta-analysis was performed with searches
through December 2016 in the following databases: PubMed, EMBASE, ScienceDirect, Google
Scholar, China National Knowledge Infrastructure (CNKI), SciELO, BIOSIS, and Web of Science.
The search strategy executed in PubMed is presented as follows:
(Intercostobrachial nerve[title/abstract]) or nervus intercostobrachialis[title/abstract]
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No date or language restrictions were applied. Identification of additional studies eligible for
the meta-analysis was performed through searching the references of all included articles.
Throughout the meta-analysis, adherence to the preferred reporting items for systematic
reviews and meta-analyses (PRISMA) guidelines were exercised (See Appendix - Table 5) [18].
Eligibility Assessment
Eligibility for inclusion in the meta-analysis was assessed by two independent reviewers. All
intraoperative or cadaveric studies that reported extractable prevalence data of ICBN origin or
branching were included. The exclusion criteria included: case reports, case series, letters to the
edito or conference abstracts. All studies published in languages not fluently spoken by any of
the authors were translated by medical professionals fluent in both English and the language of
the original manuscript. Disagreements between reviewers arising during the eligibility
assessment process were resolved by discussion and consensus.
Data Extraction
Data from included studies was independently extracted by three reviewers. Extracted data
included year, country, sample size (number of patients and number of axillas), prevalence of
ICBN, ICBN origin, branching pattern of ICBN and the prevalence of communication with the
brachial plexus. In the event of any discrepancies in the data, authors of the original were
contacted for clarification when possible.
Statistical Analysis
The single-categorical and multi-categorical pooled prevalence estimates were calculated using
MetaXL version 2.0 by EpiGear Pty Ltd. (Wilston, Queensland, Australia) [19]. A random effects
model was used for all statistical analyses. Heterogeneity was assessed by both the Chi2 test and
the I2 statistic. For the Chi2 test, a p-value of < 0.10 for Cochran’s Q served as an indicator of
significant heterogeneity among the studies analyzed [20]. The results of the I2 statistic were
interpreted as follows: zero percent to 40% might not be important; 30%- 60% could indicate
moderate heterogeneity; 50% - 90% could indicate substantial heterogeneity; and 75% - 100%
could represent considerable heterogeneity [20].
Subgroup analysis was performed on the basis of type of study (cadaveric vs. operative) and
geographical origin of the study. Statistically significant differences between analyzed groups
were determined by their confidence intervals. If the confidence intervals of any two rates
overlapped, the differences were regarded as statistically insignificant [19]. Lastly, sensitivity
was assessed by a separate analysis of studies with sample sizes greater than 100 to probe
further for potential sources of heterogeneity.
Results
Study Identification
The flow of studies through the meta-analysis is presented in Figure 1. The search of the major
electronic databases identified an initial 509 articles, with an additional one article identified
in the search of the references of included studies. A total of 102 articles were assessed for
eligibility using full-texts, of which 86 were excluded and 16 were included into the meta-
analysis.
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FIGURE 1: PRISMA flow chart of the study identification and
inclusion in the meta-analysis
Characteristics of Included Studies
The characteristics of the studies that have been included in the meta-analysis are summarized
in Table 1. Sixteen studies (1,567 axillas) [1, 3-4, 13,17, 21,28] were included in the meta-
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analysis. Five studies were performed on cadaveric specimens [13, 15, 22, 25, 27], 10 were
performed intraoperatively [1,3-4, 14, 16- 17, 21, 24, 26, 28], and one study [23] examined both
cadavers and operative subjects. The studies ranged in year from 1999 to 2016 and had a vast
geographic breakdown with 10 from Asia, three from Europe, and one each from North
America, South America, and Oceania.
Study Country Type
n = (# half-bodies
studied)
# of half-bodies with ICBN
(%)
O’Rourke
1999
Australia Cadaveric 28 28 (100%)
Cunnick 2001
United
Kingdom
Operative 50 45 (90%)
Wu 2001 China Operative 204 203 (100%)
Yin 2004 China Cadaveric 50 48 (96%)
Li 2005 China
Cadaveric &
Operative
70 70 (100%)
Zhao 2005 China Operative 151 151 (100%)
Ge 2006 China Cadaveric 5 5 (100%)
Loukas 2006 Grenada/USA Cadaveric 200 200 (100%)
Zhang 2006 China Operative 216 207 (96%)
Zhao 2008 China Cadaveric 32 31 (97%)
Verma 2009 India Operative 69 69 (100%)
Khan 2012
United
Kingdom
Operative 73 73 (100%)
Kubala 2013
Czech
Republic
Operative 113 107 (95%)
Soares 2014 Brazil Operative 100 99 (99%)
Zhu 2014 China Operative 156 156 (100%)
Kumar 2016 India Operative 50 50 (100%)
TABLE 1: Characteristics of included studies
ICBN - intercostobrachial nerve
Prevalence of the Intercostobrachial Nerve
A total of 16 studies (1,567 axillas) reported data on the prevalence of the ICBN. The overall
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pooled prevalence of the ICBN in axillas was 98.4% (95%CI: 97.1-99.4) (Figure 2). No significant
differences in prevalence were noted during geographic or study type subgroup analysis.
Sensitivity analysis also proved to not reveal any notable differences. Data on the prevalence of
the ICBN is presented in Table 2.
FIGURE 2: Forest plot for pooled prevalence of the
intercostobrachial nerve
Category # of studies (# of axillas) Prevalence of ICBN: % (95% CI) I2: % (95% CI)*
Overall 16 (1567) 98.4 (97.1-99.4) 64.4 (39.3-79.1)
Cadaveric 5 (315) 98.3 (95.3-100) 51.0 (0.0-82.0)
Operative 10 (1182) 98.3 (96.5-99.4) 70.5 (43.5-84.5)
Asia 10 (1003) 98.6 (97.2-99.6) 53.4 (4.7-77.2)
Europe 3 (236) 95.7 (88.6-100) 80.5 (38.9-93.8)
Sensitivity (n≥100) 7 (1140) 98.6 (96.7-99.7) 76.7 (51.4-88.9)
TABLE 2: Prevalence of the intercostobrachial nerve in human axillas
Origin of the intercostobrachial nerve
Twelve studies (922 ICBNs) reported data on the origin of the ICBN. The most common origin
was from the T2 vertebral level, with 90.6% (95%CI: 83.1-98.7) of ICBNs originating at that
level. A pure T2 origin was followed by T2 & T3 combined origin [3.4% (95%CI: 0.0-9.7)] and T1
& T2 combined origin [2.9% (95%CI: 0.0-8.8)]. To further clarify, combined origin was listed as
such when two separate roots were observed unifying into one common ICBN. Subgroup and
sensitivity analysis did not yield any significant findings or differences between groups. Data
regarding the origin of the ICBN is presented in Table 3.
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Category
# of studies
(# of
nerves)
T1 %
(95%
CI)
T1 & T2
% (95%
CI)
T1, T2, & T3
% (95% CI)  
T2 %
(95%
CI)  
T2 & T3
% (95%
CI)  
T3 %
(95%
CI)  
T2, T3, & T4
% (95% CI)  
I2: %
(95%
CI)*
Overall 12 (922)
0.8
(0.0-
4.5)
2.9 (0.0-
8.8)
1.1 (0.0-5.1)
90.6
(83.1-
98.7)
3.4 (0.0-
9.7)
0.6
(0.0-
4.0)
0.6 (0.0-4.0)
94.3
(91.8-
96.1)
Cadaveric 5 (312)
0.8
(0.0-
13.9)
1.4 (0.0-
16.2)
0.8 (0.0-
13.9)
88.3
(68.4-
100)
6.4 (0.0-
29.7)
0.8
(0.0-
13.9)
1.4 (0.0-
16.0)
95.8
(92.8-
97.6)
Operative 7 (568)
1.0
0.0-
3.6)
4.9 (1.2-
10.6)
1.5 (0.0-4.5)
89.7
(82.6-
95.4)
2.0 (0.0-
6.3)
0.6
(0.0-
2.8)
0.4 (0.0-2.2)
82.9
(66.1-
91.3)
Asia 8 (576)
1.0
(0.0-
5.3)
3.2 (0.0-
9.7)
1.5 (0.0-6.3)
92.0
(87.5-
100)
1.3 (0.0-
5.8)
0.5
(0.0-
3.7)
0.5 (0.0-3.7)
91.1
(85.0-
94.8)
Europe 2 (118)
0.4
(0.0-
7.4)
3.4 (0.0-
16.0)
0.4 (0.0-7.4)
90.5
(71.8-
100)
3.2 (0.0-
15.5)
1.7
(0.0-
11.8)
0.4 (0.0-7.4)
86.7
(47.8-
96.6)
Sensitivity
(n≥100)
3 (503)
1.4
(0.0-
15.6)
5.4 (0.0-
26.1)
2.8 (0.0-
19.8)
76.8
(38.9-
98.8)
12.9 (0.0-
39.8)
0.6
(0.0-
12.2)
0.2 (0.0-9.3)
98.2
(96.8-
99.0)
TABLE 3: Types of origin of the intercostobrachial nerve from the lateral cutaneous
branches of the intercostal nerves (vertebral levels)
Branching of the Intercostobrachial Nerve
A total of 12 studies (1,234 ICBNs) reported data on the branching pattern of the ICBN.
Detailed information on the ICBN branching data is presented in Table 4. The ICBN most
commonly existed as a single trunk [47.0% (95%CI: 23.8-67.9)] (Figure 3) followed closely by a
bifurcating pattern [42.2% (95%CI: 19.8-63.4)] (Figure 4). Subgroup analysis revealed that the
presence of a bifurcating ICBN was more frequently seen in cadaveric studies versus
intraoperative studies [65.3% (95%CI: 13.6-100) vs. 30.2% (95%CI: 6.3-57.6)], albeit not
significantly. Further subgroup and sensitivity analysis did not reveal any significant findings.
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Category
# of
studies
(# of
nerves)
Single
Trunk
% (95%
CI)
Unification of two
branches into
Single Trunk %
(95% CI)
Unification of two
branches into Single
Trunk with Re-Branching
% (95% CI)
Total
Bifurcation
% (95% CI)
Multiple
Branches
% (95%
CI)
I2: %
(95%
CI)*
Overall
12
(1234)
47.0
(23.8-
67.9)
2.7 (0.0-12.0) 0.6 (0.0-6.5)
42.2 (19.8-
63.4)
7.5 (0.0-
20.8)
98.2
(97.7-
98.6)
Cadaveric 4 (284)
23.9
(0.0-
75.9)
2.9 (0.0-35.2) 0.9 (0.0-26.4)
65.3 (13.6-
100)
7.0 (0.0-
46.9)
97.6
(96.0-
98.6)
Operative 8 (950)
59.2
(27.4-
83.1)
2.5 (0.0-15.0) 0.5 (0.0-8.5)
30.2 (6.3-
57.6)
7.6 (0.0-
25.3)
98.6
(98.1-
98.9)
Asia 9 (916)
39.9
(11.8-
69.3)
1.2 (0.0-12.1) 0.5 (0.0-9.3)
50.5 (19.7-
78.5)
7.9 (0.0-
27.2)
98.6
(98.1-
98.9)
Europe 2 (118)
60.3
(25.8-
89.6)
9.5 (0.0-33.0) 1.7 (0.0-15.6)
23.3 (1.0-
56.5)
5.3 (0.0-
24.8)
91.4
(70.0-
97.5)
Sensitivity
(n ≥100)
5 (913)
61.8
(19.0-
93.8)
0.9 (0.0-16.3) 0.1 (0.0-11.4)
29.1 (0.0-
65.6)
7.9 (0.0-
34.7)
99.2
(98.9-
99.4)
TABLE 4: Branching patterns of the intercostobrachial nerve
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FIGURE 3: Cadaver displaying a single trunk intercostobrachial
nerve
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FIGURE 4: Cadaver displaying a bifurcating intercostobrachial
nerve
Bifurcation Type
Eight studies (381 bifurcating ICBNs) reported data on the specific pattern of bifurcation. It was
revealed that 36.6% (95%CI: 25.2-48.7) of ICBNs bifurcate into equal branches, that is
specifically branches of equal size. Unequal bifurcation was observed in 63.4% (95%CI: 51.3-
74.8) of cases and was denoted when branches following a bifurcation were not of equal
size [I2=79.0% (95%CI: 59.0-89.2), Cochran’s Q, p <0.001].
Communication with the Brachial Plexus
Four studies (479 ICBNs) included information of neural anastomoses with the brachial plexus
(medial cord or medial brachial cutaneous nerve of the arm]. It was noted that 41.3% (95%CI:
6.8-80.6) of ICBNs had these communicating branches [I2=98.3% (95%CI: 97.3-98.9), Cochran’s
Q, p < 0.001].
Discussion
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The ICBN is a nerve of significant importance in surgical procedures involving the axillary
region. Damage to the ICBN is associated with significant morbidity and is believed to be
involved with postoperative pain and sensory loss [1, 9-10].
Our analysis demonstrated the overall prevalence of the ICBN to be 98.4% and that it most
often exists as a single trunk (47.0%) originating from the T2 vertebral level (90.6%). Subgroup
analysis revealed little variation in the results aside from that of ICBN branching. Branching
subgroups differed largely based on the modality of the study (cadaveric vs. operative). When
examining the statistics for bifurcation alone, it is notable that ICBNs examined in cadavers
(65.3%) had more than twice the rate of bifurcation than those assessed intraoperatively
(30.2%). We posit two concepts from these differences. The first being that due to the limited
field of view intraoperatively, as well as the inability to freely dissect tissue without
consequences, may limit the branches which are identified in-vivo. It should be noted that
these differences may help explain why nerves which are successfully identified and protected
can still present with postoperative complications [1]. It was noted in Kumar (2016) that six
months following the procedure, 20% of patients who had successful ICBN preservation still
experienced numbness and paresthesia [1]. However, in addition to a bifurcating ICBN, this
may also be due to stretching of the nerve by retractors or other intraoperative stress placed on
the nerve fibers. The secondary factor contributing to the cadaveric-intraoperative discord may
be that nerves that do bifurcate, have a propensity to do so in an unequal fashion (63.4%
unequal versus 36.6% equal bifurcation). As such, surgeons may easily identify the larger trunk
but neglect to identify the smaller branch of the nerve, placing it at a higher risk of operative
injury.
Preservation of the ICBN is very important and should be factored into operative plans. There
are cases where ICBN conservancy will not be possible, but in those where it is possible, it was
associated with an insignificant increase in operative time of approximately five minutes [1].
The neural fibers travelling within the ICBN appear to vary, as there are cases of known ICBN
loss where patients have no postoperative neural deficits [1]. As it is difficult to determine
preoperatively the role of the ICBN in a patient, a vital sensory function of the nerve should be
assumed. It was also discovered in our analysis that 41.3% of ICBNs contributed anastomosing
branches to the brachial plexus, namely the medial cord or medial brachial cutaneous nerve.
This lends some explanation to the unpredictability of deficits that can present in patients [13].
Losses in sensation or pain have been noted in locations ranging from the medial side of the
proximal arm, axillary region, to the anterior chest wall [1, 17].
Various techniques of dissection have been proposed throughout the history of ICBN
examination. Some techniques advocate that a superficial blunt dissection should be conducted
from the site of axillary incision towards the lateral edge of the pectoralis muscle [12]. The ICBN
can be identified consistently in an anterior position during exposure of the long thoracic and
thoracodorsal nerves [13, 29-30]. Extra care should be particularly exercised in the area of the
second intercostal space where ICBN origin is most likely (90.6%). Surgeons should however,
consider than many ICBNs do receive fibers from either the first or third intercostal nerves as
well. Some also note that dissection could propagate inferiorly from an axillary incision,
traveling from the axillary vessels, layer-by-layer until positive nerve identification [4]. It is also
noted that in the area of the inferior margin of the pectoralis minor muscle and dissection deep
to the pectoralis minor, should be avoided if possible due to risks of ICBN injury [31].
Operative procedures of the axilla are often associated with varying stages of breast cancer
management. The ICBN can be damaged from any number of reasons ranging from traction to
transection [32]. Additionally, damaged nerves may also develop neuromas that can further
complicate the clinical picture [1, 32]. Surgeons in some cases must make decisions that have
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consequences in order to get the proper margins in oncologic surgery. It should, however, be
standard to exercise protective practices towards the ICBN when possible. ICBN neuralgia and
post-mastectomy pain syndrome can be successfully managed with loco-regional anesthetic
techniques, however, overall reduction in incidence should be the primary goal [4, 32].
Our meta-analysis was limited by a number of factors involved in inconsistent reporting and
small sample sizes. Some studies presented origins from the first intercostal nerve or third
intercostal nerve as separate data. It was unclear to whether these origins were duplications or
simply contributing fibers and thus had to be excluded from analyses where this information
could have skewed results. Additionally, high heterogeneity persisted despite our subgroup
analyses, thus we postulate this may have resulted from the intrinsically variable nature of the
ICBN. This high level of heterogeneity was sustained in defiance of the fact that pooled
prevalences were largely consistent between groups, pointing further towards the notion that
there is indeed high anatomic variability. There was an overall lack of reporting by studies on
factors such as gender and laterality, which could have provided for additional subgroup
analyses. The overwhelming majority of studies were performed on women, however, Loukas
(2006) noted no differences between genders [15]. Limited data from regions such as Africa,
North America, Oceania and South America precluded analyses of other regions aside from
Europe and Asia. Detailed data was absent from many studies regarding branching site or
details on the symmetry of the post-division branches.
Future studies need to be performed to further elucidate the behavior of the terminal branching
of the ICBN as well as its anastomotic behavior with the brachial plexus. There is also the
possibility to investigate the use of landmarks or relationships with adjacent structures as a
means for intraoperative nerve identification. Structures such as the lateral thoracic vein
discussed in O’Rourke (1999) could be a potential candidate [13]. Finally, histologic studies
should be performed to examine for possibilities of microscopic branching and further identify
the types of neural fibers running within the nerve. Investigating this may help explain cases of
postoperative neuropathy where nerves were successfully spared intraoperatively.
Supplementation with future research will provide valuable information for surgeons and
ideally result in more positive outcomes for patients undergoing procedures in the region.
Conclusions
The ICBN is a prevalent anatomical structure with significant variability in origin and
branching pattern. It is at considerable risk during operative procedures in the axilla, especially
those involved in breast cancer management. Injury to ICBN fibers has been associated with
post-procedural pain, paresthesia, and ultimately reduced the quality of life. Surgeons need to
exercise caution and should adopt measures to protect the ICBN, its branches, and
anastomosing fibers if possible. The information presented in this study, accompanied by
careful surgical practice, could help to reduce significant complications during mastectomy and
axillary dissection.
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RESULTS  
Study
selection
17
Give numbers of studies screened, assessed for eligibility, and included in the review,
with reasons for exclusions at each stage, ideally with a flow diagram.
8
Study
characteristics
18
For each study, present characteristics for which data were extracted (e.g., study size,
PICOS, follow-up period) and provide the citations.
8
Risk of bias
within studies
19
Present data on risk of bias of each study and, if available, any outcome level
assessment (see item 12).
N/A
Results of
individual
studies
20
For all outcomes considered (benefits or harms), present, for each study: (a) simple
summary data for each intervention group (b) effect estimates and confidence intervals,
ideally with a forest plot.
8-9
Synthesis of
results
21
Present results of each meta-analysis done, including confidence intervals and
measures of consistency.
8-9
Risk of bias
across studies
22 Present results of any assessment of risk of bias across studies (see Item 15). N/A
Additional
analysis
23
Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses,
meta-regression [see Item 16]).
8-9
DISCUSSION  
Summary of
evidence
24
Summarize the main findings including the strength of evidence for each main outcome;
consider their relevance to key groups (e.g., healthcare providers, users, and policy
makers).
10-13
Limitations 25
Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level
(e.g., incomplete retrieval of identified research, reporting bias).
12-13
Conclusions 26
Provide a general interpretation of the results in the context of other evidence, and
implications for future research.
13
FUNDING  
Funding 27
Describe sources of funding for the systematic review and other support (e.g., supply of
data); role of funders for the systematic review.
13
TABLE 5: PRISMA 2009 checklist
Completed checklist for the preferred reporting items for systematic reviews and meta-analyses (PRISMA) 2009 guidelines
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